Systemic sclerosis test gets CE mark, 7/16
July 2016—Protagen gained CE marking for its Multilisa BICD2 test. BICD2 is a proprietary biomarker discovered by Protagen using the SeroTag technology platform.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
FFPE DNA repair kit, 7/16
July 2016—Oxford Gene Technology introduced its SureSeq FFPE DNA Repair Mix for repairing a broad range of damage in formalin-fixed, paraffin-embedded–derived DNA.
Embedder station, 7/16
July 2016—Tanner Scientific’s second-generation embedder station, the TN1550, with a dispensing module and separate cold plate, is now available.
Myriad Web portal, acquisition, 7/16
July 2016—Myriad Genetics launched a Web portal on ms360.myriad.com that allows patients to access their personal test results and to access other tools and ideas to help them make health care decisions. The first phase of the portal will provide access to test results for the company’s hereditary cancer and prostate cancer tests.
Qiagen adds Horizon QC, 7/16
July 2016—Qiagen announced that it will offer an extensive package of quality control data, generated through the application of Horizon Discovery Group’s reference standards, with its GeneReader NGS System.
Ultrasensitive assays, 7/16
July 2016—Aushon BioSystems has launched the Ciraplex Ultra Ultrasensitive Assays with femtogram/milliliter level detection to address multiple biomarkers in a wide range of therapeutic areas.
Automated DNA purification, 7/16
July 2016—Mawi DNA Technologies announced that Omega Bio-tek has successfully developed an automated DNA purification method from iSwab-DNA with its Mag-Bind Blood and Tissue DNA HDQ chemistry on the Hamilton MicroLabStar automation platform.
Cellular detection kit, 7/16
July 2016—The Cyto-ID Autophagy Detection Kit 2.0 from Enzo Life Sciences measures autophagic vacuoles and monitors autophagic flux in lysosomally inhibited live cells using a novel dye that selectively labels accumulated autophagic vacuoles.
Sysmex, Siemens extend partnership, 7/16
July 2016—Sysmex and Siemens Healthineers Laboratory Diagnostics announced an extension to their partnership through at least 2020.
Liquid biopsy assay, 7/16
July 2016—Foundation Medicine has launched an analytically validated and accurate blood-based circulating tumor DNA assay that provides patients and oncologists with a new option for comprehensive genomic profiling when a tissue biopsy is not feasible or when tissue is not available.